VF
CATX icon

Virtu Financial’s Perspective Therapeutics CATX Stock Holding History

Virtu Financial’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,888
Closed -$62K – 1655
2026
Q1 		$62K Buy
+14,888
New +$62.9K ﹤0.01% 1255
2024
Q2 		– Sell
-11,576
Closed -$138K – 1361
2024
Q1 		$138K Buy
+11,576
New +$98.7K 0.01% 868
2023
Q4 		– Sell
-1,273
Closed -$3K – 1605
2023
Q3 		$3K Buy
+1,273
New +$5.94K ﹤0.01% 1169
2023
Q1 		– Sell
-6,700
Closed -$17K – 1575
2022
Q4 		$17K Buy
+6,700
New +$22.1K ﹤0.01% 1295
2022
Q3 		– Sell
-2,447
Closed -$8K – 1760
2022
Q2 		$8K Buy
+2,447
New +$7.47K ﹤0.01% 1440
2022
Q1 		– Sell
-4,084
Closed -$16K – 1542
2021
Q4 		$16K Sell
4,084
-582
-12% -$3.1K ﹤0.01% 1534
2021
Q3 		$29K Buy
4,666
+1,511
+48% +$10.3K ﹤0.01% 1353
2021
Q2 		$25K Sell
3,155
-14,619
-82% -$128K ﹤0.01% 1397
2021
Q1 		$194K Sell
17,774
-4,785
-21% -$72.3K 0.01% 1102
2020
Q4 		$102K Buy
22,559
+14,558
+182% +$64.3K 0.01% 1048
2020
Q3 		$47K Buy
+8,001
New +$52.1K 0.01% 828
2019
Q4 		$10K Sell
1,547
-5,215
-77% -$22.9K ﹤0.01% 1366
2019
Q3 		$22K Buy
+6,762
New +$24.5K ﹤0.01% 1280
2019
Q2 		– Sell
-1,574
Closed -$6K – 1480
2019
Q1 		$6K Sell
1,574
-3,776
-71% -$14.7K ﹤0.01% 1350
2018
Q4 		$16K Buy
5,350
+2,815
+111% +$12.1K ﹤0.01% 1394
2018
Q3 		$13K Sell
2,535
-676
-21% -$3.76K ﹤0.01% 1433
2018
Q2 		$14K Buy
+3,211
New +$14.9K ﹤0.01% 1887
2018
Q1 		– Sell
-5,491
Closed -$22K – 2003
2017
Q4 		$22K Buy
5,491
+1,229
+29% +$5.72K ﹤0.01% 2205
2017
Q3 		$22K Buy
+4,262
New +$23.9K ﹤0.01% 2334

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Virtu Financial's CATX Position: Q2 2026 in Review

Virtu Financial sold out of Perspective Therapeutics (CATX) in Q2 2026, closing a stake of 14,888 shares — an estimated $62K sold.

Virtu Financial first reported a position in CATX in Q3 2017 and held it in 19 quarters. The position peaked at $194K in Q1 2021. 132 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Virtu Financial reported no remaining Perspective Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 14,888 Perspective Therapeutics shares in Q2 2026, an estimated $62K.
  • Virtu Financial first reported a position in Perspective Therapeutics in Q3 2017 and held it in 19 quarters.
  • Virtu Financial's Perspective Therapeutics position peaked at $194K in Q1 2021.
  • 132 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.